CClinicalTrials.gg
CompletedNCT07609615Updated Sep 30, 2026

Pneumoperitoneum Pressure and Lung Ultrasound Atelectasis

An interventional study of 10 mmHg Pneumoperitoneum and 14 mmHg Pneumoperitoneum in Atelectasis, Perioperative Complication and Pneumoperitoneum, sponsored by Engin Çetin. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Engin Çetin · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
112
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Elective laparoscopic cholecystectomy may lead to perioperative atelectasis due to pneumoperitoneum-related diaphragmatic elevation and impaired respiratory mechanics. Lung ultrasound (LUS) provides a noninvasive bedside method for evaluating perioperative aeration loss. This prospective randomized controlled study aims to compare the effects of low-pressure (10 mmHg) and standard-pressure (14 mmHg) pneumoperitoneum on perioperative atelectasis assessed by LUS in patients undergoing laparoscopic cholecystectomy under general anesthesia. Changes in LUS scores, respiratory mechanics, oxygenation, and postoperative clinical outcomes will also be evaluated.

Read the detailed description

Elective laparoscopic cholecystectomy may cause perioperative atelectasis due to pneumoperitoneum-related impairment of respiratory mechanics. Lung ultrasound (LUS) is a noninvasive bedside tool that can evaluate perioperative lung aeration loss and atelectasis.

This prospective randomized single-blind controlled trial aims to compare the effects of low-pressure (10 mmHg) and standard-pressure (14 mmHg) pneumoperitoneum on perioperative atelectasis assessed by LUS in patients undergoing elective laparoscopic cholecystectomy under general anesthesia. Patients will be randomized into two groups according to pneumoperitoneum pressure level.

LUS assessments will be performed before pneumoperitoneum, at the end of surgery before extubation, and at the postoperative first hour. The primary outcome will be the change in LUS score from baseline to the end of surgery. Secondary outcomes will include respiratory mechanics, oxygenation parameters, postoperative oxygen requirement, postoperative pain, nausea-vomiting, and recovery outcomes.

02

Conditions studied

  • Atelectasis
  • Perioperative Complication
  • Pneumoperitoneum

Keywords

  • Atelectasis
  • Pneumoperitoneum
  • Perioperative Complication
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged between 18 and 65 years
  • ASA physical status I-II
  • Scheduled for elective laparoscopic cholecystectomy under general anesthesia
  • Body mass index (BMI) \<30 kg/m²
  • Ability to provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • Chronic pulmonary disease
  • Recent respiratory tract infection
  • Thoracic deformity or previous thoracic surgery
  • Preoperative pulmonary pathology
  • Morbid obesity
  • Pregnancy
  • Emergency surgery
  • Conversion to open surgery
  • Requirement for protocol-violating pneumoperitoneum pressure modification
  • Refusal to participate in the study
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
112 participants (actual)

Study arms

  • Active comparator
    10 mmHg Pneumoperitoneum

    Patients in this group will undergo laparoscopic cholecystectomy with pneumoperitoneum maintained at 10 mmHg.

    Diagnostic Test: 10 mmHg Pneumoperitoneum

  • Active comparator
    14 mmHg Pneumoperitoneum

    Patients in this group will undergo laparoscopic cholecystectomy with pneumoperitoneum maintained at 14 mmHg.

    Diagnostic Test: 14 mmHg Pneumoperitoneum

Interventions

  • Diagnostic test10 mmHg Pneumoperitoneum

    Laparoscopic cholecystectomy will be performed with intra-abdominal pressure maintained at 10 mmHg during insufflation. Standard anesthesia and surgical protocols will be followed.

  • Diagnostic test14 mmHg Pneumoperitoneum

    Laparoscopic cholecystectomy will be performed with intra-abdominal pressure maintained at 14 mmHg during insufflation. Standard anesthesia and surgical protocols will be followed.

05

What researchers measure

Primary outcomes

  1. Total Lung Ultrasound Score (LUS) Change From Baseline

    Perioperative lung aeration loss and atelectasis will be assessed using the Lung Ultrasound Score (LUS) during laparoscopic cholecystectomy performed under two different pneumoperitoneum pressures (10 mmHg vs 14 mmHg). Lung ultrasonography will be performed on predefined anterior and lateral chest wall regions bilaterally. Each lung region will be scored from 0 to 3 according to the degree of aeration loss, and the total LUS will range from 0 to 24. Higher scores indicate greater loss of lung aeration and more severe atelectasis.

    Time frame: T0: After anesthesia induction and before pneumoperitoneum initiation (baseline); T1: At the end of surgery before extubation; T2: 1 hour after arrival in the post-anesthesia care unit (PACU)

Secondary outcomes

  1. Peak Airway Pressure (cmH₂O)

    Intraoperative peak airway pressure (cmH₂O) during laparoscopic cholecystectomy will be measured using the anesthesia ventilator and compared between the low-pressure pneumoperitoneum (10 mmHg) and standard-pressure pneumoperitoneum (14 mmHg) groups.

    Time frame: T0: Before pneumoperitoneum initiation (baseline); T1: 30 minutes after pneumoperitoneum initiation; T2: At the end of surgery before pneumoperitoneum desufflation

  2. Dynamic Lung Compliance (mL/cmH₂O) Measured by Mechanical Ventilator

    Intraoperative dynamic lung compliance (mL/cmH₂O), measured using the anesthesia ventilator, will be compared between low-pressure pneumoperitoneum (10 mmHg) and standard-pressure pneumoperitoneum (14 mmHg) groups during laparoscopic cholecystectomy.

    Time frame: Baseline (before pneumoperitoneum) and 5, 15, 30, and 45 minutes after pneumoperitoneum initiation

06

Study locations

1 site
  • University of Health Sciences Kocaeli City Hospital
    İzmit, Kocaeli 41200, Turkey (Türkiye)
07

References and documents

Publications

  • Turan Civraz AZ, Saracoglu A, Saracoglu KT. Evaluation of the Effect of Pressure-Controlled Ventilation-Volume Guaranteed Mode vs. Volume-Controlled Ventilation Mode on Atelectasis in Patients Undergoing Laparoscopic Surgery: A Randomized Controlled Clinical Trial. Medicina (Kaunas). 2023 Oct 7;59(10):1783. doi: 10.3390/medicina59101783. PubMed 37893501 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT07609615
Lead sponsor
Engin Çetin
Responsible party
Engin Çetin (Principal investigator, Kocaeli City Hospital) — Sponsor-investigator
First posted
May 27, 2026
Start date
Jun 1, 2026
Primary completion
Aug 15, 2026
Completion
Aug 15, 2026
Last update
Sep 30, 2026

Study contacts

Engin Çetin
principal investigator · Kocaeli City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion